Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORA trial of adjuvant cisplatin + vinorelbine after complete resection of non-small cell lung cancer
2007-000439-24Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin and vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoints: Disease-free interval, Duration of partial response and 6 more. Started Apr 2007; status: terminated.
02
Drugs
cisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-000439-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000439-24.